Shares of Target Corp. tumbled in early trading Wednesday, after the discount retailer said it was replacing Chief Executive Brian Cornell, who has been in charge for the past 11 years, with current ...

Eli Lilly's top neuroscience executive, Anne White, is retiring after three decades with the drugmaker. Eli Lilly on Wednesday said White will remain in her post as executive vice president and ...

"Tariffs are starting to show up a bit in price," he said, noting that Home Depot posted a 1.4% increase in comparable average ticket growth - a gauge of average price paid per transaction - during ...

The company, which is the parent of TJ Maxx, Marshalls, HomeGoods, Homesense and Sierra store brands in the U.S., also beat fiscal second-quarter earnings expectations and raised its full-year outlook ...

Dow Jones Top Markets Headlines at 9 AM ET: Stock Futures Down Ahead of Fed Minutes, Investors Eye Retail Earnings | Startup ... Stock Futures Down Ahead of Fed Minutes, Investors Eye Retail Earnings ...

HLS Therapeutics agreed a new Canadian dollar-denominated credit deal aimed at boosting its financial flexibility and reducing foreign-exchange exposure and lowering the interest rate.

My friend is working on an exit plan' "I did recommend not making any sudden moves, because it could look like they are trying to hide assets." (Photo subject is a model.) Dear Quentin, Are assets - ...

Airbus employees in the U.K. plan to strike for ten days next month over a wage dispute. Unite union, representing more than 3,000 aircraft fitters and engineers at the European planemaker, said ...

Stock market will have to navigate a 'bifurcated economy' Meredith Whitney, pictured in 2023, says a 'bifurcated' U.S. economy spells trouble. Nearly two decades ago, financial analyst Meredith ...

T.J. Maxx parent TJX Cos. raised its full-year profit outlook after logging higher-than-expected earnings and sales in the latest quarter, as consumers flocked to the company's stores in search of ...

On a per-share basis, Lowe's lowered its full-year earnings guidance to between $12.10 and $12.35 from the prior range of $12.15 to $12.40. It expects adjusted earnings of $12.20 to $12.45 a share.

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...